JRJörg Reimann

Jörg Reimann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jörg Reimann has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Complexes of DNA Vaccines With Cationic, Antigenic Peptides Are Potent, Polyvalent CD8+ T-Cell-Stimulating Immunogens

    by Petra Riedl, Jörg Reimann, Reinhold Schirmbeck

    A priority in current vaccine research is the development of multivalent vaccines that support the efficient priming of long-lasting CD8+ T-cell immunity. We developed a novel vaccination strategy that used synthetic, cationic (positively charged), and antigenic peptides complexed to negatively charged nucleic acids: antigenic, major histocompatibility complex-class I-binding epitopes fused with a cationic sequence derived from the HIV tat protein (tat50–57: KKRRQRRR) were mixed with nucleic acids (e.g., CpG-containing oligonucleotides) to quantitatively form peptide/nucleic acid complexes. The injection of these complexes efficiently primed long-lasting, specific CD8+ T-cell immunity of high magnitude. This chapter describes a novel strategy to codeliver complexes of cationic/antigenic peptides bound to antigen-encoding plasmid DNA vaccines in a way that enhances the immunogenicity of both components for T cells.


  • A Stress Protein-Facilitated Antigen Expression System for Plasmid DNA Vaccines

    by Petra Riedl, Nicolas Fissolo, Jörg Reimann, Reinhold Schirmbeck

    In DNA vaccination, an exciting new immunization technique with potential applications in clinical medicine, expression plasmid DNA containing antigen-encoding sequences cloned under heterologous promoter control are delivered by techniques that lead in vivo to antigen expression in transfected cells. DNA vaccination efficiently primes both humoral and cellular immune responses. We developed a novel expression system for DNA vaccines in which a fusion protein with a small, N-terminal, viral DnaJ-like sequence (J domain) is translated in frame with C-terminal antigen-encoding sequences. The J domain stable bind to constitutively expressed, cytosolic stress protein hsp73 and triggers intracellular accumulation of antigen/hsp73 complexes. The system supports enhanced expression of chimeric antigens of >800 residues in length in immunogenic form. A unique advantage of the system is that even unstable or toxic proteins (or protein domains) can be expressed. We describe the design of DNA vaccines expressing antigens with a stress protein-capturing domain and characterize the immunogenicity of the antigens produced by this expression system.


  • Colonic lamina propria dendritic cells in mice with CD4+ T cell‐induced colitis

    by Tamara Krajina, Frank Leithäuser, Peter Möller, Zlatko Trobonjaca, Jörg Reimann

    CD11c+ (F4/80– CD68–) dendritic cells (DC) in the colonic lamina propria (cLP) of normal and immunodeficient (RAG1–/–) C57BL/6 (B6) mice show high surface expression of MHC class I/II molecules and CD1d, and low surface expression of CD40, CD80, CD86 costimulator molecules. CD4+ α β T cells from normal or MHC class II‐deficient B6 micetransferred into congenic RAG1–/– hosts induce a progressive, lethal colitis. Concomitant with colitis development, DC in the inflamed cLP increase in number and up‐regulate surface expression of CD1d, MHC class II molecules and CD40, CD80, CD86 costimulator molecules. cLP DC from non‐transplanted (healthy) and transplanted (diseased) mice produce similar amounts of IL‐12 p70 and IL‐10 in response to CD40 signaling, but the inducible IL‐12 p40 release is 5–15‐fold higher in mice with colitis than in non‐transplanted mice. Binding of IL‐12 p40 to p19 generates IL‐23. Freshly isolated cLP lymphocytes (cLPL) from transplanted, diseased mice express 3–10‐fold more p19 transcripts than cLPL from non‐transplanted, healthy mice. p19 expression by cLPL is further up‐regulated in response to CD40 ligation. Freshly isolated cLP DC from transplanted mice with colitis (but not from non‐transplanted controls) stimulate IFN‐γ (but not IL‐4 or IL‐13) release by co‐cultured NKT cells. Incolitis, DC accumulate in the cLP, show an activated surface phenotype, up‐regulate IL‐12 p40 and p19 expression, and ‘spontaneously’ stimulate NKT‐like cells. cLP DC may be interesting targets for novel therapeutic approaches to modulate mucosal T cell responses in situ.


  • Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells

    by Detlef Stober, Zlatko Trobonjaca, Jörg Reimann, Reinhold Schirmbeck

    Ld- and Kb-binding epitopes processed by murine dendritic cells (DC) pulsed with exogenous, particulate hepatitis B surface antigen (HBsAg) are presented to cytotoxic T lymphocytes (CTL). The specific and dose-dependent induction of IFN-γ release and cytotoxicity in CTL by metabolically active DC did not depend on antigenic peptides contaminating the particles, was cytochalasin D resistant, independent of the maturation state of DC, and blocked by primaquine, amiloride and NH4Cl (indicating involvement of acid proteolysis). The specific immunostimulatory phenotype of pulsed DC was maintained for about 3 h after the end of the pulse but rapidly decayed thereafter. Processing of Ld- and Kb-binding epitopes from exogenous HBsAg particles by pulsed DC for presentation was TAP independent. Surface-associated ‘empty’ (presentation-deficient) 64+ Ld molecules (defined by the mAb 64-3-7), but not trimeric (presentation-competent) 30+ Ld molecules (defined by the mAb 30-5-7) had to be available during the pulse of DC with exogenous HBsAg particles to generate 30+ Ldmolecules that present the antigenic S28–39 peptide. Exogenous β2-microglobulin present during the pulse of DC with HBsAg particles facilitated presentation of Ld- and Kb-restricted epitopes. DC generated from bone marrow progenitors in vitro, as well as splenic and liver DC (generated in vivo) presented epitopes to specific CTL. HBsAg particles thus efficiently enter an alternative processing pathway in DC that leads to presentation of epitopes to MHC class I-restricted CTL.


    • 1 January 2002
      • Vol. 22  (1) , 47-103

    The hepatic immune system.

    by Mary Jo Wick, Frank Leithäuser, Jörg Reimann

    The liver regulates T-cell homeostasis, induces T-cell tolerance, and supports intrahepatic T-cell responses against hepatotropic pathogens. Many data from clinical and preclinical systems provide supportive evidence for these diverse roles of the liver in modulating peripheral (systemic, mucosal, and intrahepatic) T-cell immunity. Little information is available on the cellular and molecular mechanisms that mediate the dual role of the liver in tolerizing T-cell responses and in supporting intrahepatic priming of T-cell responses. Understanding these immunoregulatory effects in the liver may offer insight into clinically relevant immunopathologies of this organ.